Estimation of mean sojourn time for lung cancer by chest X-ray screening with a Bayesian approach

Lung Cancer

Volumn 62, Issue 2, 2008, Pages 215-220

  Chien, Chun Ru ^b,c   Lai, Mei Shu ^a   Chen, Tony Hsiu Hsi ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Bayesian approach; Chest X ray; Lung cancer; Mean sojourn time

Indexed keywords

ADULT; AGED; ARTICLE; BAYES THEOREM; CANCER DIAGNOSIS; CANCER PATIENT; CANCER REGISTRY; CANCER SCREENING; CANCER SURVIVAL; CIGARETTE SMOKING; COMPUTER ASSISTED TOMOGRAPHY; EARLY DIAGNOSIS; FEMALE; GROWTH RATE; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG CARCINOMA; MALE; MEAN SOJOURN TIME; OVERALL SURVIVAL; PRIORITY JOURNAL; PROBABILITY; SEX DIFFERENCE; SURVIVAL TIME; TAIWAN; THORAX RADIOGRAPHY; TIME; TUMOR GROWTH;

AGED; BAYES THEOREM; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MASS CHEST X-RAY; MIDDLE AGED; SMALL CELL LUNG CARCINOMA; X-RAYS;

EID: 55049094922     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.02.020     Document Type: Article

References (25)

1. WHO's World Health Statistics [database on the Internet]. Global Burden of Disease Estimates: 2004 revision of the World Health Report; 2002 [cited September 15, 2007]. Available from: http://www.who.int/healthinfo/statistics/gbdwhoregionmortality2002.xls.
2. Luh K.T., and Chang D.B. Primary lung cancer in Taiwan. J Formos Med Assoc 91 Suppl 1 (1992) S1-S7
3. National Cancer Institute [homepage on the Internet]. Surveillance epidemiology and end results: cancer of the lung and bronchus [cited September 15, 2007]. Available from: http://seer.cancer.gov/statfacts/html/lungb.html?statfacts_page=lungb.html&x=15 &y=18.
4. Brawley O.W., and Kramer B.S. Cancer screening in theory and in practice. J Clin Oncol 23 (2005) 293-300
5. Mulshine J.L., and Sullivan D.C. Lung cancer screening. N Engl J Med 352 (2005) 2714-2720
6. Levin M.L., Tockman M.S., Frost J.K., and Ball Jr. W.C. Lung cancer mortality in males screened by chest X-ray and cytologic sputum examination: a preliminary report. Recent Results Cancer Res 82 (1982) 138-146
7. Fontana R.S. The Mayo lung project: a perspective. Cancer 89 (2000) 2352-2355
8. Melamed M.R., Flehinger B.J., Zaman M.B., Heelan R.T., Perchick W.A., and Martini N. Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest 86 (1984) 44-53
9. Flehinger B.J., Kimmel M., Polyak T., and Melamed M.R. Screening for lung cancer. The Mayo lung project revisited. Cancer 72 (1993) 1573-1580
10. Walter S.D., Kubik A., Parkin D.M., Reissigova J., Adamec M., and Khlat M. The natural history of lung cancer estimated from the results of a randomized trial of screening. Cancer Causes Cont 3 (1992) 115-123
11. Liaw Y.P., Huang Y.C., and Lien G.W. Patterns of lung cancer mortality in 23 countries: application of the age-period-cohort model. BMC Publ Health 5 (2005) 22
12. Alberg A.J., Brock M.V., and Samet J.M. Epidemiology of lung cancer: looking to the future. J Clin Oncol 23 (2005) 3175-3185
13. Young Jr JL, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA, editors. SEER summary staging manual-2000: codes and coding instructions [monograph on the Internet] NIH Pub. No. 01-4969. Bethesda, MD: National Cancer Institute; 2001 [cited November 1, 2006]. Available from: http://seer.cancer.gov/tools/ssm.
14. The BUGS Project [homepage on the Internet]. Cambridge, UK: MRC Biostatistics Unit; 1996-2004 [cited December 26, 2005]. Available from: http://www.mrc-bsu.cam.ac.uk/bugs.
15. Chen T.H., Kuo H.S., Yen M.F., Lai M.S., Tabar L., and Duffy S.W. Estimation of sojourn time in chronic disease screening without data on interval cases. Biometrics 56 (2000) 167-172
16. Colice G.L., Rubins J., and Unger M. Follow-up and surveillance of the lung cancer patient following curative-intent therapy. Chest 123 (2003) 272S-283S
17. Shen Y., and Zelen M. Screening sensitivity and sojourn time from breast cancer early detection clinical trials: mammograms and physical examinations. J Clin Oncol 19 (2001) 3490-3499
18. Saccomanno G., Archer V.E., Auerbach O., Saunders R.P., and Brennan L.M. Development of carcinoma of the lung as reflected in exfoliated cells. Cancer 33 (1974) 256-270
19. Geddes D.M. The natural history of lung cancer: a review based on rates of tumour growth. Br J Dis Chest 73 (1979) 1-17
20. Bach P.B., Silvestri G.A., Hanger M., and Jett J.R. Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132 (2007) 69S-77S
21. Yau G., Lock M., and Rodrigues G. Systematic review of baseline low-dose CT lung cancer screening. Lung Cancer 58 (2007) 161-170
22. Day N.E. Estimating the sensitivity of a screening test. J Epidemiol Community Health 39 (1985) 364-366
23. Rubins J., Unger M., and Colice G.L. Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition). Chest 132 (2007) 355S-367S
24. van Iersel C.A., de Koning H.J., Draisma G., Mali W.P., Scholten E.T., Nackaerts K., et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 120 (2007) 868-874
25. Andriole G.L., Levin D.L., Crawford E.D., Gelmann E.P., Pinsky P.F., Chia D., et al. Prostate cancer screening in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial: findings from the initial screening round of a randomized trial. J Natl Cancer Inst 97 (2005) 433-438